Company overview
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing ILMN with another company.
| Daily close (USD) | $264.57 |
| Market capitalization (USD) | $39,950,070,000 |
| Price / earnings (TTM) | 48.42 |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read ILMN's valuation metrics
Company size
Illumina Inc's recorded market capitalization is $39,950,070,000. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
ILMN's recorded P/E is 48.42: about $48.42 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Illumina Inc with Aurora
Use the snapshot above to ask a specific question about ILMN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow ILMN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.